Related Experiment Videos
The transforming activities of MDM2 in cultured neonatal rat astrocytes
S Kondo1, T Morimura, G H Barnett
1Department of Neurosurgery/S80, Brain Tumor Center/Cancer Center, The Cleveland Clinic Foundation, Ohio 44195, USA.
Abstract:
Although the molecular events regulating the pathogenesis of malignant astrocytomas remains unclear, the inactivation of tumor suppressor genes may be a key factor. The inactivation of p53 by mutation or deletion, however, is not the only obligatory step in astrocytoma genesis. The MDM2 protein has been shown to bind to and downmodulate p53 function, and to have oncogenic capacity. The MDM2 gene is also amplified and overexpressed in a subset of malignant astrocytomas without p53 mutation. Here we show that overexpression of MDM2 promoted the DNA synthesis of cultured neonatal rat astrocytes (RNB cells), abrogated the transcriptional activity of wild-type p53, conferred invasive activity, and subsequently induced the transformation from astrocytes to high-grade astrocytomas. Intriguingly, MDM2 enhanced the expression of angiogenic mitogens; basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in RNB cells. These results indicate that MDM2 may play an important role in the progression of astrocytomas, by not only conferring invasive activity but also stimulating the expression of angiogenic growth factors.
Insights
MDM2 overexpression drives malignant astrocytoma development by promoting DNA synthesis, inhibiting p53, and increasing invasion. It also stimulates expression of angiogenic factors like bFGF and PDGF, crucial for tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Pathogenesis
Background:
- Malignant astrocytoma pathogenesis involves complex molecular events, with tumor suppressor gene inactivation being a key factor.
- While p53 inactivation is implicated, it's not the sole event in astrocytoma genesis.
- The MDM2 protein interacts with p53, inhibiting its function and possessing oncogenic potential, with MDM2 gene amplification observed in some astrocytomas lacking p53 mutations.
Purpose of the Study:
- To investigate the role of MDM2 overexpression in astrocytoma development.
- To determine if MDM2 influences astrocyte proliferation, invasiveness, and angiogenic factor expression.
Main Methods:
- Overexpression of MDM2 in cultured neonatal rat astrocytes (RNB cells).
- Assessing DNA synthesis, p53 transcriptional activity, and invasive potential.
- Measuring the expression levels of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF).
Main Results:
- MDM2 overexpression promoted DNA synthesis in RNB cells.
- MDM2 abrogated the transcriptional activity of wild-type p53.
- Overexpression of MDM2 conferred invasive activity and induced astrocyte transformation into high-grade astrocytomas.
- MDM2 enhanced the expression of angiogenic mitogens, bFGF and PDGF, in RNB cells.
Conclusions:
- MDM2 plays a significant role in astrocytoma progression.
- MDM2 contributes to astrocytoma development by promoting invasiveness.
- MDM2 stimulates the expression of angiogenic growth factors, further supporting its role in tumor progression.